AMGN

Amgen (AMGN)

About Amgen (AMGN)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Details

Daily high

$278.00

Daily low

$272.32

Price at open

$273.44

52 Week High

$346.85

52 Week Low

$253.30

Market cap

149.4B

Dividend yield

3.24%

Volume

2,077

Avg. volume

3.0M

P/E ratio

35.58

Amgen News